Skip to main navigation

Home
About
Liver Disease
Pipeline
News
Investors
Contact
- Contact Us
- Careers

Press enter to begin your search

Main navigation

Home
About
Liver Disease
Pipeline
News
Investors
Contact
- Contact Us
- Careers

Menu

Investor Relations navigation

Overview
News Releases
Events & Presentations
Stock Information
Financials & Filings
Corporate Governance
Investor Resources

News Releases

News Releases

Year:

Items per page

Summary Toggle ContraVir Pharmaceuticals Announces Completion of Phase 1 with CRV431

Summary Toggle

September 18, 2018

View News Release >
Summary Toggle ContraVir Pharmaceuticals Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018

Summary Toggle

August 30, 2018

View News Release >
Summary Toggle ContraVir Pharmaceuticals Completes Data Analysis of Second Cohort in Part 1 of the Phase 1/2a Study of CRV431

Summary Toggle

August 7, 2018

View News Release >
Summary Toggle ContraVir Pharmaceuticals Provides an Update to Corporate Objectives

Summary Toggle

August 6, 2018

View News Release >
Summary Toggle ContraVir Pharmaceuticals Reports Progress in Phase 1/2A Trial of CRV431

Summary Toggle

July 23, 2018

View News Release >
Summary Toggle ContraVir Pharmaceuticals to Present at Virtual Investor Conference

Summary Toggle

July 5, 2018

View News Release >
Summary Toggle ContraVir Pharmaceuticals Announces $10.8 Million in Expected Gross Proceeds from Recently Expired Rights Offering

Summary Toggle

June 29, 2018

View News Release >
Summary Toggle ContraVir Pharmaceuticals Initiates Dosing of CRV431 in First In-Human Trial

Summary Toggle

June 25, 2018

View News Release >
Summary Toggle ContraVir Pharmaceuticals Announces Data on Optimized Formulation of TXL™

Summary Toggle

June 21, 2018

View News Release >
Summary Toggle ContraVir Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements

Summary Toggle

June 20, 2018

View News Release >

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
…
Next page
Last page

Displaying 11 - 20 of 151 results

Get Important News and Updates by Email Subscribe

© 2019 ContraVir Pharmaceuticals | Disclaimer & Terms of Use